—#162284

Product

Re-Entry" Malecot Nephrostomy Catheter Set, Product Number: M0064101040, GTIN: 08714729008446 The Malecot Nephrostomy Catheter Set is intended to establish percutaneous nephrostomy drainage and is indicated for the following: Diagnostic Indications: " Antegrade pyelography " Pressure/perfusion study (Whitaker test) Therapeutic Indications: " Nephrostomy catheter drainage " Perfusion chemolysis of renal stones " Percutaneous nephrolithotomy " Percutaneous resection and coagulation of urothelial tumors

FDA product code: GBO — Catheter, Nephrostomy, General & Plastic Surgery
Device class: Class 1
Medical specialty: General, Plastic Surgery
Affected lot / code info: Expiration Date Range: 3/27/2018 9/25/2021; Batch: 16852983 18912864 20404111 16969146 18932466 20458384 16987703 19157072 20491745 17078511 19318043 20517724 17159358 19338399 20567074 17248134 19596298 20567075 17672818 19623064 20593962 17780452 19705478 20658862 17910342 19737920 20682997 17960225 19850692 20735792 17976830 19934631 20769252 18100917 20065714 20830243 18106456 20169834 20884298 18172896 20198263 20909294 18280357 20284828 21027051 18398908 20312727 21101918 18821698 20330766 21181528 18876334

Why it was recalled

Certain Malecot Nephrostomy Catheters are breaking at the mid-shaft bond during use.

Root cause (FDA determination)

Under Investigation by firm

Action the firm took

The firm, Boston Scientific, sent an "Urgent Medical Device Product Removal - Immediate Action Required" letter dated 12/12/2017 to its consignees. The letter described the product, problem and actions to be taken. The consignees were instructed to: identify and remove all affected batches from your inventory; immediately discontinue use of and segregate the affected product, and return it to Boston Scientific. Distributors were notified that this removal is to the customer level and asked to notify any customers who received affected product. Consignees were asked to complete and return the Replay Verification Tracking Form (even if you do not have any product to return) via email: BSCFieldActionCenter@bsci.com or Fax to: Field Action Center at 1-866-213-1806. If you have any questions, your local Sales Representative can answer any questions that you may have regarding this removal or contact Vice President , Regulatory Affairs at 508-683-4398 or email: Donna.Gardner@bsci.com or BSCFieldActionCenter@bsci.com.

Recalling firm

Firm: Boston Scientific Corporation
Address: 100 Boston Scientific Way, Marlborough, Massachusetts 01752-1234

Distribution

Distribution pattern: Worldwide Distribution: US (nationwide) in the following: AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KA, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, including the District of Columbia and Puerto Rico; and countries of: Argentina, Bolivia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Panama, Peru, Venezuela, Australia, Bangladesh, Botswana, China, Kuwait, Lebanon, Macau, Malaysia, Philippines, Saudi Arabia, Singapore, South Africa, South Korea, Turkey, United Arab Emirates, and Zimbabwe.

Timeline

Recall initiated: 2017-12-12
Terminated: 2019-10-24
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #162284. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.